Scientists watch Parkinson's patients for clues to future treatments

NCT ID NCT05779475

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

Summary

This study aims to observe how people with moderate Parkinson's disease fare over time while on their usual medications. It will follow 96 participants for up to 2 years, tracking their movement symptoms during 'off' periods when medication wears off. A key goal is to see if participants might be suitable for future advanced cell therapy trials.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Clinical Neuroscience

    Cambridge, CB2 0PY, United Kingdom

  • Joe C.Wen & Fam CTR for Adv Care

    Irvine, California, 92612, United States

  • Keio University Hospital

    Shinjuku-ku, Tokyo, 160-8582, Japan

  • NY Presbyt Hosp-W Cornell Med

    New York, New York, 10021, United States

  • NYU Langone Health

    New York, New York, 10016, United States

  • Neurologimottagningen Lund

    Lund, 222 42, Sweden

  • Region Skane Skanes Universitetssjukhus

    Lund, 222 42, Sweden

  • University of Cambridge - Clinical Neuroscience

    Cambridge, CB2 0PY, United Kingdom

Conditions

Explore the condition pages connected to this study.